Nikulski Financial’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-1,727
| Closed | -$235K | – | 134 |
|
2023
Q4 | $235K | Sell |
1,727
-8,108
| -82% | -$1.1M | 0.09% | 121 |
|
2023
Q3 | $1.2M | Buy |
9,835
+2,003
| +26% | +$245K | 0.5% | 50 |
|
2023
Q2 | $994K | Buy |
7,832
+858
| +12% | +$109K | 0.41% | 61 |
|
2023
Q1 | $901K | Buy |
6,974
+7
| +0.1% | +$904 | 0.4% | 62 |
|
2022
Q4 | $915K | Buy |
6,967
+4,782
| +219% | +$628K | 0.44% | 55 |
|
2022
Q3 | $256K | Hold |
2,185
| – | – | 0.13% | 104 |
|
2022
Q2 | $257K | Sell |
2,185
-40
| -2% | -$4.71K | 0.13% | 112 |
|
2022
Q1 | $290K | Buy |
+2,225
| New | +$290K | 0.12% | 104 |
|
2020
Q3 | – | Sell |
-4,902
| Closed | -$670K | – | 106 |
|
2020
Q2 | $670K | Buy |
4,902
+1,543
| +46% | +$211K | 0.47% | 55 |
|
2020
Q1 | $362K | Buy |
+3,359
| New | +$362K | 0.32% | 65 |
|